Literature DB >> 1393836

Capsules of Escherichia coli, expression and biological significance.

K Jann1, B Jann.   

Abstract

Escherichia coli may cause intestinal or extraintestinal infections. Generally, extraintestinal E. coli are encapsulated. The capsules are important virulence determinants, which enable the pathogenic bacteria to evade or counteract the unspecific host defense during the early (preimmune) phase of infection. They interfere with the action of complement and phagocytes. This effect is generally transient and overcome by capsule-specific antibodies in the immune phase of the host defense. In some cases, capsules are not or only poorly immunogenic, as a result of structural relationship or identity with host material. Strains with such capsules (e.g., K1 or K5) are very virulent. Bacterial capsules consist of acidic polysaccharides, which are made up from oligosaccharide repeating units. The capsules of E. coli are divided into two groups, which differ in chemistry, biochemistry, and genetic organization. All capsular polysaccharides are chromosomally determined: those of group I close to his and those of group II close to serA. The biosynthesis and surface expression have been extensively studied with representatives of group II capsular polysaccharides. It could be shown that their biosynthesis is directed from a gene block that determines the synthesis of the polysaccharide, its translocation across the cytoplasmic membrane, as well as its surface expression in a coordinate process. The chemical nature of group II capsular polysaccharides, as well as the mechanism(s) of their biosynthesis and expression, is presented.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1393836     DOI: 10.1139/m92-116

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN: 0008-4166            Impact factor:   2.419


  31 in total

1.  Genetic organization of the Escherichia coli K10 capsule gene cluster: identification and characterization of two conserved regions in group III capsule gene clusters encoding polysaccharide transport functions.

Authors:  B R Clarke; R Pearce; I S Roberts
Journal:  J Bacteriol       Date:  1999-04       Impact factor: 3.490

2.  Detection of the Escherichia coli group 2 polysaccharide capsule synthesis Gene kpsM by a rapid and specific PCR-based assay.

Authors:  James R Johnson; Timothy T O'Bryan
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

3.  Transcriptional organization and regulation of expression of region 1 of the Escherichia coli K5 capsule gene cluster.

Authors:  D A Simpson; T C Hammarton; I S Roberts
Journal:  J Bacteriol       Date:  1996-11       Impact factor: 3.490

4.  K2 Capsule Depolymerase Is Highly Stable, Is Refractory to Resistance, and Protects Larvae and Mice from Acinetobacter baumannii Sepsis.

Authors:  Hugo Oliveira; Ana Mendes; Alexandra G Fraga; Alice Ferreira; Andreia I Pimenta; Dalila Mil-Homens; Arsénio M Fialho; Jorge Pedrosa; Joana Azeredo
Journal:  Appl Environ Microbiol       Date:  2019-08-14       Impact factor: 4.792

5.  Molecular basis of virulence.

Authors:  T J Mitchell
Journal:  Arch Dis Child       Date:  1998-03       Impact factor: 3.791

6.  Monitoring processivity and length control of a carbohydrate polymerase.

Authors:  Matthew R Levengood; Rebecca A Splain; Laura L Kiessling
Journal:  J Am Chem Soc       Date:  2011-07-25       Impact factor: 15.419

7.  Effect of bile on Vibrio parahaemolyticus.

Authors:  J L Pace; T J Chai; H A Rossi; X Jiang
Journal:  Appl Environ Microbiol       Date:  1997-06       Impact factor: 4.792

8.  The pathogenicity island-associated K15 capsule determinant exhibits a novel genetic structure and correlates with virulence in uropathogenic Escherichia coli strain 536.

Authors:  György Schneider; Ulrich Dobrindt; Holger Brüggemann; Gábor Nagy; Britta Janke; Gabriele Blum-Oehler; Carmen Buchrieser; Gerhard Gottschalk; Levente Emödy; Jörg Hacker
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

9.  Enhanced protection by use of a combination of anticapsule and antilipopolysaccharide monoclonal antibodies against lethal Escherichia coli O18K5 infection of mice.

Authors:  H Frasa; B Benaissa-Trouw; L Tavares; K van Kessel; M Poppelier; K Kraaijeveld; J Verhoef
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

10.  Coexpression of colanic acid and serotype-specific capsular polysaccharides in Escherichia coli strains with group II K antigens.

Authors:  W J Keenleyside; D Bronner; K Jann; B Jann; C Whitfield
Journal:  J Bacteriol       Date:  1993-10       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.